Anastasios Konidaris

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

AMRX

Current role

CFO

7 calls Latest call 2025-10-30

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$600,750	—	$2,249,995	—	$423,590	$19,159	$3,293,494
2024	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$580,731	—	$1,866,575	—	$386,100	$18,927	$2,852,333
2023	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$563,327	—	$855,505	—	$453,902	$18,531	$1,891,266
2022	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$550,000	—	$1,876,807	—	$289,493	$16,886	$2,733,186
2021	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$550,000	—	$1,770,757	—	$326,912	$16,327	$2,663,996
2020	Amneal Pharmaceuticals, Inc. (AMRX)	EVP & Chief Financial Officer	$427,308	—	$1,747,367	—	$327,608	$6,216	$2,508,499

Earnings-call appearances and filed executive appointments or departures, newest first.